AGP Executive Report
Last update: 5 hours agoWHO cannabis risk update: The WHO has revised its assessment of non-medical cannabis risks for the first time in a decade, warning that newer, higher-THC products and changing use patterns have increased dangers—especially for adolescents and young people—while noting rising demand for treatment of cannabis-related disorders. Medical cannabis & public health: A Gallup snapshot shows record-high marijuana use in the US (with edibles also rising) as alcohol use hits a record low, fueling debate over whether people are swapping one substance for another. Hemp regulation in focus (Texas): A multi-part look at Texas hemp rules highlights ongoing legal fights over how delta-8 and other hemp-derived cannabinoids are enforced versus what the statute allows. On-the-ground weed control: Newport Beach approved a shift away from synthetic herbicides on athletic fields toward organic and mechanical weed control plus periodic sod replacement. Hemp at home / small growers: New Zealand’s hemp industry pushes to expand small-scale growing to drive innovation, while noting remaining restrictions that limit some health and feed uses. Cannabis in the courts: A Florida sealed grand jury report alleges $10M was diverted from a Medicaid overbilling settlement to political efforts tied to marijuana legalization defeat. Enforcement snapshot: Police in Sydney seized $1.5M in drugs including cannabis and THC gummies, charging two men.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.